FDA Inspection 1235880 — NYC Health + Hospitals/Bellevue

NYC Health + Hospitals/Bellevue — FEI 2473466

The FDA completed an inspection of NYC Health + Hospitals/Bellevue on March 28, 2024 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 28, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)